Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
AGIOS PHARMACEUTICALS, INC. (AGIO) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/03/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/03/2023 8-K Quarterly results
Docs: "Agios Reports Business Highlights and Second Quarter 2023 Financial Results –Announced Positive Results from Phase 2 Portion of the RISE UP Pivotal Study of Mitapivat in Sickle Cell Disease&#59; On Track to Enroll First Patient in Phase 3 Portion of the Study in Q4 2023"
05/25/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
04/26/2023 ARS Form ARS - Annual Report to Security Holders:
04/26/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/26/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2023 8-K Quarterly results
02/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/23/2023 S-3ASR Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
02/23/2023 10-K Annual Report for the period ended December 31, 2022
02/23/2023 8-K Quarterly results
Docs: "Agios Reports Fourth Quarter and Full Year 2022 Financial Results – Completed Enrollment in Phase 2 RISE UP Study of PYRUKYND® in Sickle Cell Disease –"
02/14/2023 SC 13G Rock Springs Capital Management LP reports a 5.4% stake in AGIOS PHARMACEUTICALS, INC.
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 2.7% stake in AGIOS PHARMACEUTICALS INC
02/14/2023 SC 13G ARMISTICE CAPITAL, LLC reports a 5% stake in AGIOS PHARMACEUTICALS, INC.
02/08/2023 SC 13G/A STATE STREET CORP reports a 5.8% stake in AMENDED FILING AGIOS PHARMACEUTICALS INC
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 5 Form 5 - Annual statement of changes in beneficial ownership of securities:
01/25/2023 SC 13G/A BlackRock Inc. reports a 8.7% stake in AGIOS PHARMACEUTICALS INC
01/09/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agios Unveils 2023-2026 Value-driving Catalysts Enabling Company's Vision to Transform Patient Outcomes in Rare Diseases",
"Presentation at the 41st Annual J.P. Morgan Healthcare Conference"
01/03/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
12/16/2022 8-K Quarterly results
12/06/2022 8-K Quarterly results
11/03/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/03/2022 8-K Quarterly results
10/27/2022 8-K Quarterly results
10/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Amended and Restated Severance Benefits Plan",
"Amended and Restated Severance Benefits Plan"
10/06/2022 SC 13G/A JPMORGAN CHASE & CO reports a 2.7% stake in AGIOS PHARMACEUTICALS, INC.
09/26/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
09/19/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Agios Appoints Cecilia Jones as Chief Financial Officer"
09/12/2022 SC 13G/A FMR LLC reports a 3.7% stake in AGIOS PHARMACEUTICALS INC
09/07/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
08/15/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy